Merck & Co Inc

Merck lowers profit outlook, partly due to $200 million expected tariff hit
Nurphoto | Nurphoto | Getty Images Merck on Thursday lowered its full-year profit guidance, citing $200 million in estimated costs for tariffs and a charge tied to a recent deal. The company now expects its 2025 adjusted earnings to come in between $8.82 and $8.97, down slightly from a previous outlook of 8.88 to $9.03 […]
Read More
Here are the top 15 companies for career growth in Singapore, according to LinkedIn
DBS Bank tops LinkedIn’s 2025 Top Companies in Singapore list. Lim Weixiang – Zeitgeist Photos | E+ | Getty Images The technology, banking and consulting industries dominated LinkedIn’s 2025 Top Companies in Singapore list published this month, which ranks the best workplaces for career growth in the city-state. The networking giant tracked and assessed companies […]
Read More
Pharmaceutical stocks fall as Trump doubles down on tariffs threat
The Lilly Biotechnology Center in San Diego, California, on March 1, 2023. Mike Blake | Reuters Shares of drugmakers fell on Wednesday after President Donald Trump doubled down on plans to impose tariffs on pharmaceuticals imported into the U.S. Shares of U.S.-based companies Eli Lilly, AbbVie, Bristol Myers Squibb and Regeneron all fell about 4% […]
Read More
Stocks making the biggest moves premarket: Walmart, Target, Apple, Pfizer, Eli Lilly, Ford and more
Check out the companies making headlines before the bell. Pharmaceutical stocks – Shares of U.S. companies in the pharmaceutical industry fell after President Donald Trump said late Tuesday that he’s going to announce ” very shortly a major tariff on pharmaceuticals .” Pfizer and Merck shares each dropped more than 4%, while Eli Lilly shed […]
Read More
Trump’s tariffs are a new challenge for Big Pharma. Here are the best-positioned stocks
Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump’s goal of bringing manufacturing back to the United States has put the industry in the administration’s crosshairs. Trump first floated the idea of imposing tariffs of as much as 25% on imported pharmaceuticals in mid-February. Since then, he has repeated […]
Read More
Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up
Signage at the AstraZeneca facility in Gaithersburg, Maryland, US, on Monday, Aug. 26, 2024. Graeme Sloan | Bloomberg | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The race to develop more convenient […]
Read More
Family office dealmaking doubled in February with bets on crab shells, nuclear reactors and more
A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high net worth investor and consumer. Sign up to receive future editions, straight to your inbox. Last month, family offices made at least 48 direct investments, double that of the month prior, according to data […]
Read More
European markets fall as traders digest latest Trump tariff reprieve; Luxury stocks decline
European markets were broadly lower Friday, rounding off a volatile week marked by whipsawing policy on U.S. tariffs, the latest rate cut from the European Central Bank, German fiscal reforms and a regional defense spending boost. The regional Stoxx 600 index was down 0.65% at 10:20 a.m. U.K. time, with retail and household goods stocks […]
Read More
Air France-KLM pops 16% after profit beat; Europe markets open higher ahead of ECB meeting
European markets opened higher on Thursday as investors look ahead to the latest monetary policy decision of the European Central Bank. Source
Read More